Clinical trial
Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
NCT02980263 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- November 15, 2016
- Completion date
- November 30, 2017
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
kawasaki disease